Centenial Surgical Suture Ltd.
Snapshot View

51.95 -2.70 ▼-4.9%

12 August 2022, 04:01:00 PM
Volume: 70

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.centenialindia.com
Market Cap 18.95 Cr.
Enterprise Value(EV) 27.99 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.72 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 30.22 Trailing Twelve Months Ending 2022-03
Industry PE 44.77 Trailing Twelve Months Ending 2022-03
Book Value / Share 77.91 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.67 Calculated using Price: 51.95
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.36 Cr. 3,648,300 Shares
FaceValue 10
Company Profile
Centenial Surgical Suture Ltd., founded in 1995, manufactures a broad range of quality sterile needled sutures, with state-of-the-art manufacturing and packaging equipment, sophisticated processes designed and operated by Centenial's competent and devoted staff. Centenial Sutures is a combination of Craftmanship, the Latest Production Technology, Strictest Quality Control, Care and Dedication, results in Products of Incomparable Quality. Centenial is a company with a Surgeon's eye for Quality. At Centenial doing business the fair way is their Foremost Concern, by Guaranteeing Courteous, Fair and Honest Service, enough inventory to meet any order size and pricing. Centenial is confident that it can prove its flexibility, capacity and attention for Quality and Consistency in manufacturing world class sutures in India.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.94%
1 Week
-5.46%
1 Month
+0.58%
3 Month
-6.14%
6 Month
-20.20%
1 Year
+1.96%
2 Year
+34.41%
5 Year
-14.70%
10 Year
+100.97%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.80 10.37 7.72 7.86 6.56 7.98 4.88 3.52 2.23
Return on Capital Employed (%) 13.36 14.22 11.74 14.02 14.84 16.75 12.64 8.65 7.27
Return on Assets (%) 3.66 3.64 2.89 3.17 2.77 3.60 2.06 1.38 0.95

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 17 19 21 23 25 26 28 29 30 30
Non Curr. Liab. 4 4 3 3 3 3 3 10 9 7
Curr. Liab. 26 27 31 27 28 26 26 31 32 24
Minority Int.
Equity & Liab. 48 50 55 53 56 55 57 69 70 61
Non Curr. Assets 5 5 4 4 4 4 5 11 9 8
Curr. Assets 43 45 51 49 52 51 52 58 61 53
Misc. Exp. not W/O
Total Assets 48 50 55 53 56 55 57 69 70 61

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 54 51 52 51 53 53 56 56 37 44
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 54 51 52 51 53 53 56 56 37 44
Total Expenditure -49 -46 -47 -47 -48 -48 -51 -50 -32 -40
PBIDT 5 5 5 5 5 5 5 6 5 5
Interest -2 -1 -2 -2 -2 -2 -2 -2 -2 -2
Depreciation -1 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation -1 -1 -1 -1 -1 -1 -1 -1 -1 0
Exceptional Items
PAT 2 2 2 2 2 2 2 1 1 1
Adjusted EPS 4 5 5 4 5 4 6 4 3 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 -2 2 2 2 2 5
Cash Fr. Inv. -1 0 0 0 -2 -1 -1 -1 -1 0
Cash Fr. Finan. 2 -1 1 1 2 -1 -1 0 -1 -5
Net Change 2 -2 1 -1 0 0 -1 0 0 0
Cash & Cash Eqvt 3 1 2 1 1 1 0 1 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 44.78 44.78 44.78 44.78 44.78 44.78 44.78 44.78 44.78
Public 55.22 55.22 55.22 55.22 55.22 55.22 55.22 55.22 55.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 13 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
In Compliances with Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed herewith copies of the Newspaper Advertisement of the Standalone Un-Audited Financial Results of the Company for quarter ended June 30 2022 published in all the editions of The Free Press Journal and in Mumbai Edition of Navshakti (Regional Newspaper) on August 13 2022.
Fri, 12 Aug 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 12 2022 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015.
With reference to the above captioned subject we wish to inform you that the Board of Directors of the Company at their meeting held on Friday the August 12 2022 approved the following:? Standalone Un-Audited Financial Results for the quarter ended June 30 2022 as per Regulation 33 of SEBI (LODR) Regulations 2015.The said meeting commenced at 04:30 p.m. and concluded at 04:45 p.m. Kindly take the same on your record.
Fri, 12 Aug 2022
Standalone Un-Audited Financial Results For The Quarter Ended June 30 2022
In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit following documents:1). Standalone Un-Audited Financial Results for the quarter ended June 30 2022.2). Limited Review Report for the quarter ended June 30 2022.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
High Decrease 6 Months High Decrease 6 Months
Close Crossing 50 SMA From Above Close Crossing 50 SMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Centenial Surgical Suture Ltd.

Can I Buy Centenial Surgical Shares now?

What is the Share Price of Centenial Surgical?

What is the Relative Strength Index (RSI) Value of Centenial Surgical?

What is the Market Capital (MCAP) of Centenial Surgical?

What are the key metrics to analyse Centenial Surgical?

What is the Price Performance of Centenial Surgical?